Literature DB >> 9811823

The reactive site loop of the serpin SCCA1 is essential for cysteine proteinase inhibition.

C Schick1, D Brömme, A J Bartuski, Y Uemura, N M Schechter, G A Silverman.   

Abstract

The high-molecular-weight serine proteinase inhibitors (serpins) are restricted, generally, to inhibiting proteinases of the serine mechanistic class. However, the viral serpin, cytokine response modifier A, and the human serpins, antichymotrypsin and squamous cell carcinoma antigen 1 (SCCA1), inhibit different members of the cysteine proteinase class. Although serpins employ a mobile reactive site loop (RSL) to bait and trap their target serine proteinases, the mechanism by which they inactivate cysteine proteinases is unknown. Our previous studies suggest that SCCA1 inhibits papain-like cysteine proteinases in a manner similar to that observed for serpin-serine proteinase interactions. However, we could not preclude the possibility of an inhibitory mechanism that did not require the serpin RSL. To test this possibility, we employed site-directed mutagenesis to alter the different residues within the RSL. Mutations to either the hinge or the variable region of the RSL abolished inhibitory activity. Moreover, RSL swaps between SCCA1 and the nearly identical serpin, SCCA2 (an inhibitor of chymotrypsin-like serine proteinases), reversed their target specificities. Thus, there were no unique motifs within the framework of SCCA1 that independently accounted for cysteine proteinase inhibitory activity. Collectively, these data suggested that the sequence and mobility of the RSL of SCCA1 are essential for cysteine proteinase inhibition and that serpins are likely to utilize a common RSL-dependent mechanism to inhibit both serine and cysteine proteinases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811823      PMCID: PMC24842          DOI: 10.1073/pnas.95.23.13465

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  The behavior and significance of slow-binding enzyme inhibitors.

Authors:  J F Morrison; C T Walsh
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1988

Review 2.  The mechanism by which serpins inhibit thrombin and other serine proteinases.

Authors:  P A Patston; P G Gettins; M Schapira
Journal:  Ann N Y Acad Sci       Date:  1994-04-18       Impact factor: 5.691

3.  Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition.

Authors:  T Komiyama; C A Ray; D J Pickup; A D Howard; N A Thornberry; E P Peterson; G Salvesen
Journal:  J Biol Chem       Date:  1994-07-29       Impact factor: 5.157

4.  Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate.

Authors:  P A Patston; P Gettins; J Beechem; M Schapira
Journal:  Biochemistry       Date:  1991-09-10       Impact factor: 3.162

5.  Squamous cell carcinoma antigen is a new member of the serine protease inhibitors.

Authors:  Y Suminami; F Kishi; K Sekiguchi; H Kato
Journal:  Biochem Biophys Res Commun       Date:  1991-11-27       Impact factor: 3.575

6.  Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzyme.

Authors:  D Brömme; P R Bonneau; P Lachance; B Wiederanders; H Kirschke; C Peters; D Y Thomas; A C Storer; T Vernet
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

7.  Evidence for a tetrahedral intermediate complex during serpin-proteinase interactions.

Authors:  N R Matheson; H van Halbeek; J Travis
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

8.  Purification and characterization of alpha 1-antichymotrypsin-like protease inhibitor that regulates prohormone thiol protease involved in enkephalin precursor processing.

Authors:  V Y Hook; R T Purviance; A V Azaryan; G Hubbard; T J Krieger
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

9.  Alpha-2-antiplasmin: a serpin with two separate but overlapping reactive sites.

Authors:  J Potempa; B H Shieh; J Travis
Journal:  Science       Date:  1988-08-05       Impact factor: 47.728

10.  Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3.

Authors:  D Pei; G Majmudar; S J Weiss
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

View more
  21 in total

1.  Sequence conservation in the chagasin family suggests a common trend in cysteine proteinase binding by unrelated protein inhibitors.

Authors:  Daniel J Rigden; Vladimir V Mosolov; Michael Y Galperin
Journal:  Protein Sci       Date:  2002-08       Impact factor: 6.725

2.  Multiple domains of endopin 2A for serpin cross-class inhibition of papain.

Authors:  Shin-Rong Hwang; Vivian Y H Hook
Journal:  Arch Biochem Biophys       Date:  2007-03-21       Impact factor: 4.013

Review 3.  SERPINB3 and B4: From biochemistry to biology.

Authors:  Yu Sun; Namratha Sheshadri; Wei-Xing Zong
Journal:  Semin Cell Dev Biol       Date:  2016-09-13       Impact factor: 7.727

4.  Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors.

Authors:  Ke-Feng Lei; Bing-Ya Liu; Xiao-Qing Zhang; Xiao-Long Jin; Yan Guo; Min Ye; Zheng-Gang Zhu
Journal:  Exp Ther Med       Date:  2011-09-21       Impact factor: 2.447

Review 5.  Serpins in arthropod biology.

Authors:  David A Meekins; Michael R Kanost; Kristin Michel
Journal:  Semin Cell Dev Biol       Date:  2016-09-04       Impact factor: 7.727

6.  The immunosuppressive functions of two novel tick serpins, HlSerpin-a and HlSerpin-b, from Haemaphysalis longicornis.

Authors:  Fanqi Wang; Zhenyu Song; Jing Chen; Qihan Wu; Xia Zhou; Xiaohua Ni; Jianfeng Dai
Journal:  Immunology       Date:  2019-11-10       Impact factor: 7.397

7.  Proteome-wide analysis of protein abundance and turnover remodelling during oncogenic transformation of human breast epithelial cells.

Authors:  Tony Ly; Aki Endo; Alejandro Brenes; Marek Gierlinski; Vackar Afzal; Andrea Pawellek; Angus I Lamond
Journal:  Wellcome Open Res       Date:  2018-05-02

8.  Human SERPINB12 Is an Abundant Intracellular Serpin Expressed in Most Surface and Glandular Epithelia.

Authors:  Jason Z Niehaus; Misty Good; Laura E Jackson; John A Ozolek; Gary A Silverman; Cliff J Luke
Journal:  J Histochem Cytochem       Date:  2015-07-28       Impact factor: 2.479

9.  An intracellular serpin regulates necrosis by inhibiting the induction and sequelae of lysosomal injury.

Authors:  Cliff J Luke; Stephen C Pak; Yuko S Askew; Terra L Naviglia; David J Askew; Shila M Nobar; Anne C Vetica; Olivia S Long; Simon C Watkins; Donna B Stolz; Robert J Barstead; Gary L Moulder; Dieter Brömme; Gary A Silverman
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

10.  SCCA1/SERPINB3 promotes oncogenesis and epithelial-mesenchymal transition via the unfolded protein response and IL6 signaling.

Authors:  Namratha Sheshadri; Joseph M Catanzaro; Alex J Bott; Yu Sun; Erica Ullman; Emily I Chen; Ji-An Pan; Song Wu; Howard C Crawford; Jianhua Zhang; Wei-Xing Zong
Journal:  Cancer Res       Date:  2014-09-11       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.